CRY2 and chronic myelogenous leukemia, BCR-ABL1 positive: In comparison, the response of the circadian genes to 6h of treatment with EX527 in CML and CLL patient samples was virtually identical (Figure 6B) with the exception of Cry2 which was slightly up-regulated in CML.